Skip to content
+1 (888) 687-4334 | sales@mountainside-medical.com
Free US shipping over $100
Free US shipping over $100
Login
Click or scroll to zoom
Tap or pinch to zoom
Regadenoson Injection Prefilled Syringe 0.4 mg by Hikma
Regadenoson Injection Prefilled Syringe 0.4 mg by Hikma

Regadenoson Injection Prefilled Syringe 0.4 mg per 5mL

by Hikma Injectables
Year End Sale 32%
$ 275.95
$ 189.00
SKU 00641-6253-01
*Mountainside Medical does not fill personal prescriptions Medical Professional License Required to Unlock Account

How to Order:

✔ Send an email request to: sales@mountainside-medical.com

You will receive instructions on how to create an account along with Rx Ordering Details.

(Note: Acceptable licenses must have Prescriptive Authority in the license issuing state.)

Regadenoson is an intravenous medication used as a pharmacologic stress agent in myocardial perfusion imaging (MPI) for patients who are unable to exercise sufficiently. Acting as a coronary vasodilator, it increases blood flow to the heart, mimicking the effects of physical activity for diagnostic evaluation.

Use Regadenoson is employed to help diagnose heart conditions by enhancing blood flow to the heart, aiding in the detection of coronary artery disease during a stress test. It works more quickly and selectively than other stress agents such as adenosine, making it a popular choice for stress testing procedures.

Regadenoson Injection by Hikma is a pharmacologic stress agent used in myocardial perfusion imaging (MPI) for patients unable to undergo adequate exercise stress. This prefilled syringe offers precise administration, enhancing diagnostic accuracy for cardiac assessments.

Usage: Regadenoson is used in radionuclide myocardial perfusion imaging to evaluate coronary artery disease in patients who cannot perform physical exercise stress tests.

Dosage:

  • Standard Dose: 0.4 mg administered as a rapid intravenous injection (10 seconds) followed by a saline flush.
  • Do not repeat the dose within 24 hours.

CDC Guidelines: While the CDC doesn't have specific regadenoson guidelines, it underscores the importance of using diagnostic agents in controlled environments with appropriate monitoring due to potential cardiac effects.

Details and Features:

  • Concentration: 0.4 mg per 5 mL
  • Volume: 5 mL prefilled syringe
  • Ease of Use: Prefilled for precise and straightforward administration
  • Rapid Action: Provides quick onset for effective MPI
  • Selective A2A Receptor Agonist: Minimizes respiratory side effects

Mechanism of Action: Regadenoson selectively activates A2A adenosine receptors, causing coronary vasodilation and increased blood flow in the heart. This mimics the effects of exercise, enabling visualization of coronary blood flow and identifying coronary artery disease through imaging.

Directions for Use:

  • Administer 0.488 mg intravenously over 10 seconds.
  • Follow immediately with a 5 mL saline flush.
  • Ensure appropriate monitoring and emergency equipment are available.

Warnings:

  • Contraindicated in patients with certain cardiac conditions, such as unstable angina or severe hypotension.
  • Exercise caution in patients with chronic obstructive pulmonary disease (COPD) or asthma.
  • Monitor for potential arrhythmias and hypotension.

Side Effects: Possible side effects include:

  • Dyspnea
  • Headache
  • Flushing
  • Chest discomfort
  • Dizziness In case of severe adverse effects, initiate appropriate medical interventions immediately.

Regadenoson Injection by Hikma delivers reliable, rapid-onset pharmacologic stress for accurate cardiac imaging, ensuring effective cardiovascular diagnostics in patients unable to exercise.

Regadenoson Injection Prefilled Syringe 0.4 mg per 5mL
Regadenoson Injection Prefilled Syringe 0.4 mg per 5mL
$ 275.95 $ 189.00
🔒 Medical License Required
Regadenoson Injection Prefilled Syringe 0.4 mg – Frequently Asked Questions (FAQs)
  • What is Regadenoson Injection used for?

    Regadenoson is used as a coronary vasodilator during a cardiac nuclear stress test (myocardial perfusion imaging) for patients who cannot exercise adequately.

  • How is Regadenoson Injection administered?

    It is administered as a quick intravenous (IV) injection (bolus) by a healthcare professional, usually in a hospital or cardiac imaging center, followed by an injection of a radioactive tracer.

  • How does Regadenoson work?

    Regadenoson increases blood flow in the coronary arteries, mimicking the effects of exercise so that areas of the heart with reduced blood supply can be detected during the scan.

  • What are the common side effects of Regadenoson?

    Common side effects include shortness of breath, chest discomfort, flushing, headache, dizziness, abdominal pain, or nausea. Most side effects are short-lived and resolve within 15–30 minutes.

  • Who should NOT receive Regadenoson?

    It should not be given to patients with certain types of heart block (unless they have a pacemaker), severe hypotension, or history of severe allergic reaction to regadenoson. Use with caution in patients with asthma or COPD due to risk of bronchospasm.

  • How long do the effects of Regadenoson last?

    The main effects last for a few minutes, but minor side effects can persist for 15 minutes or more.

  • What should I tell my doctor before receiving Regadenoson?

    Inform your provider about all medical conditions, especially asthma, COPD, heart problems, or allergies. Also, list all medications and supplements you're taking.

  • Should I avoid anything before my stress test with Regadenoson?

    Yes. You should avoid caffeine (coffee, tea, chocolate, energy drinks, soda) and theophylline-containing medications for at least 12 hours before the test, as they can interfere with the effects of regadenoson.

  • Can I take my medications before the test?

    Continue most medications, but check with your healthcare team about any specific medications to withhold, especially those that could affect the test results.

  • Are there any serious risks or rare side effects?

    Rarely, regadenoson can cause severe arrhythmias, heart attack, very low blood pressure, or severe allergic reactions. These are managed immediately in a clinical setting.

  • Is Regadenoson safe for use in pregnancy or while breastfeeding?

    Its safety during pregnancy and breastfeeding is not well established. Inform your doctor if you are pregnant, might be pregnant, or breastfeeding.

  • Can Regadenoson be given to children?

    Regadenoson is primarily used in adults. Its use in children is not well established and is typically avoided unless specifically directed by a specialist.

  • What if I experience severe symptoms after administration?

    Let medical staff know immediately if you feel severe chest pain, trouble breathing, or become faint—they are prepared to treat side effects rapidly.

  • Are there any drug interactions with Regadenoson?

    Caffeine and theophylline-containing products can reduce its effect. Dipyridamole can increase its effects. Always tell your provider all drugs and supplements you use.

  • Do I need someone to drive me home after the test?

    Most patients can go home on their own after observation, but if you feel unwell or if sedatives were used with the test, arrange for someone to drive you home.

Search Any Type of Product, Medication, or Alignment